Carteolol hydrochloride is a non-selective beta-adrenergic receptor blocker frequently prescribed in ophthalmology to reduce intraocular pressure and treat glaucoma. Analytical laboratories utilize high-quality… Read more
Carteolol hydrochloride is a non-selective beta-adrenergic receptor blocker frequently prescribed in ophthalmology to reduce intraocular pressure and treat glaucoma. Analytical laboratories utilize high-quality reference standards of this active pharmaceutical ingredient to ensure the accuracy and reliability of their testing processes. This category provides an essential range of related compounds, including pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope-labelled standards, which are critical for comprehensive impurity profiling and rigorous quality control. These materials support researchers in method development and validation, ensuring that pharmaceutical preparations meet regulatory specifications. By using these analytical standards, laboratories can precisely identify and quantify trace-level impurities or metabolites during stability testing and routine batch analysis, maintaining the safety and efficacy standards required for ophthalmic therapeutic agents.